Want to see IN:ABBOTINDIA full AI Analyst Report?

Abbott India Limited (ABBOTINDIA) Price & Analysis

1 Followers

ABBOTINDIA Stock Chart & Stats

₹28003.45

-₹205.00(-0.73%)

At close: Jul 27 4:00 PM EDT

₹28003.45

-₹205.00(-0.73%)

Day’s Range― - ―

52-Week Range₹25,164.00 - ₹32,771.15

Previous CloseN/A

Volume6.60K

Average Volume (3M)628.00

Market Cap

₹561.32B

Enterprise Value₹530.02K

Total Cash (Recent Filing)₹23.86B

Total Debt (Recent Filing)₹1.72B

Price to Earnings (P/E)34.8

Beta0.43

Next Earnings

Nov 05, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield1.99%

Share Statistics

EPS (TTM)730.37

Shares Outstanding21,249,302

10 Day Avg. Volume806

30 Day Avg. Volume628

Financial Highlights & Ratios

PEG Ratio3.65

Price to Book (P/B)11.53

Price to Sales (P/S)7.95

P/FCF Ratio33.12

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)809.9

Revenue Forecast (FY)₹74.91B

Bulls Say, Bears Say

Bulls Say

Steady Revenue GrowthThe multi-year revenue increase indicates sustained demand for Abbott India’s branded medicines and healthcare products, supported by its broad therapy portfolio and established distribution and prescription-led channel presence.

Strong ProfitabilityImproving net and operating margins demonstrate effective portfolio economics and operating execution. Sustained profitability provides internal funding for product promotion, launches, working capital and other investments.

Conservative Balance SheetMinimal leverage reduces financial risk and interest burden, leaving substantial flexibility to withstand industry pressures or invest in growth. High, stable returns on equity also indicate efficient use of shareholder capital.

Bears Say

Gross Margin CompressionThe sharp margin decline may reflect an unfavorable product mix, higher input costs or pricing pressure. If persistent, it could reduce the quality and durability of earnings despite strong reported net profitability.

Slowing Revenue GrowthDecelerating growth suggests that the existing portfolio and distribution platform may be producing fewer incremental gains. Maintaining momentum could require successful launches, brand extensions or stronger market penetration.

Volatile Free Cash Flow GrowthAlthough absolute cash generation is strong, uneven year-to-year free cash flow growth reduces predictability for reinvestment and shareholder returns. The volatility warrants monitoring of working capital and operating cash conversion.

ABBOTINDIA FAQ

What was Abbott India Limited’s price range in the past 12 months?

Abbott India Limited lowest stock price was ₹25164.00 and its highest was ₹32771.15 in the past 12 months.

What is Abbott India Limited’s market cap?

Abbott India Limited’s market cap is ₹561.32B.

When is Abbott India Limited’s upcoming earnings report date?

Abbott India Limited’s upcoming earnings report date is Nov 05, 2026 which is in 70 days.

How were Abbott India Limited’s earnings last quarter?

Abbott India Limited released its earnings results on Aug 12, 2026. The company reported ₹201.7 earnings per share for the quarter, missing the consensus estimate of ₹203.45 by -₹1.75.

Is Abbott India Limited overvalued?

According to Wall Street analysts Abbott India Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Abbott India Limited pay dividends?

Abbott India Limited pays a Notavailable dividend of ₹656 which represents an annual dividend yield of 1.99%. See more information on Abbott India Limited dividends here

What is Abbott India Limited’s EPS estimate?

Abbott India Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Abbott India Limited have?

Abbott India Limited has 21,249,302 shares outstanding.

What happened to Abbott India Limited’s price movement after its last earnings report?

Abbott India Limited reported an EPS of ₹201.7 in its last earnings report, missing expectations of ₹203.45. Following the earnings report the stock price went up 0.493%.

Which hedge fund is a major shareholder of Abbott India Limited?

Currently, no hedge funds are holding shares in IN:ABBOTINDIA

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Abbott India Limited

Abbott India Limited is a pharmaceutical enterprise that conducts its operations across India. The company provides an extensive portfolio of medicinal products designed for a broad spectrum of therapeutic areas, including women's health, digestive conditions, metabolic disorders, central nervous system ailments, pain management, premature labor concerns, vitamin supplementation, sleep aids, immunizations, and general consumer health items. Established in 1944, the firm was formerly known as Knoll Pharmaceuticals Limited until it officially adopted the name Abbott India Limited in July 2002. Headquartered in Mumbai, India, it operates as a subsidiary of Abbott Capital India Limited.